Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
When does the patent on ozempic run out?Ozempic ingredients list?When does ozempic lose patent in australia?Application of green chemistry to medicinal chemistry?What date does ozempic patent in canada run out?
See the DrugPatentWatch profile for Vivitrol
I don’t have enough provided information to calculate or cite a current market size figure for Vivitrol.
Vivitrol market size estimates are usually derived from one or more of the following, none of which are included in the information you provided: - Total global or U.S. sales revenue for the product (often reported by sales-intelligence firms) - Forecasts to a future year (again from market research firms) - Prescription volumes and average selling price assumptions - Growth drivers and payer coverage assumptions
Vivitrol is a brand of extended-release naltrexone. Market sizing depends on whether a source counts: - Only the specific brand (Vivitrol) - Or broader “extended-release naltrexone” across brands and formulations That choice can materially change the reported market size.
If you want market-size numbers with citations, the fastest way is to use a market-research database. Also, for exclusivity/patent context (which can affect forecast assumptions), DrugPatentWatch.com can be useful: https://www.drugpatentwatch.com/
1) Do you mean the market in the U.S. or global? 2) Are you looking for current sales ($/year) or forecasted market size for a future year? Sources: (none—no provided market-size data to cite)
Other Questions About Vivitrol :